Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Lower dose of newer clot-buster may be appropriate for some stroke patients
Categories: Stroke News & Brain Health, Scientific Conferences & Meetings
|
Published: February 20, 2020

Lower dose of newer clot-buster may be appropriate for some stroke patients

American Stroke Association International Stroke Conference – Late Breaking Science News Release (LB 1)
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Clot in brain illustration

A clot within a blood vessel interrupting blood flow to the brain.

About Stroke | Stroke treatments

copyright American Heart Association

Download (517.4 kB)
Clot in brain illustration

Clot in brain illustration

A clot within a blood vessel interrupting blood flow to the brain.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (517.4 kB) File Permalink

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association

Download (426.1 kB)
Brain illustration

Brain illustration

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution.

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (426.1 kB) File Permalink

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association

Download (558.5 kB)
Clot busted with tPA illustration

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (558.5 kB) File Permalink

Clot busting tPA administered illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association

Download (555.1 kB)
Clot busting tPA administered illustration

Clot busting tPA administered illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (555.1 kB) File Permalink

Bruce C. Campbell M.B.B.S., presents LB1

Bruce C. Campbell, M.B.B.S., presents Determining the Optimal Dose of Tenecteplase Before Endovascular Thrombectomy (EXTEND-IA TNK Part 2): A Multicenter, Randomized, Controlled Trial during the Thursday Main Event at the American Heart Association / American Stroke Association International Stroke Conference at the Los Angeles Convention Center.

copyright American Heart Association -Photo by Phil McCarten 2020

Download (2.9 MB)
 Bruce C. Campbell M.B.B.S., presents LB1

Bruce C. Campbell M.B.B.S., presents LB1

Bruce C. Campbell, M.B.B.S., presents Determining the Optimal Dose of Tenecteplase Before Endovascular Thrombectomy (EXTEND-IA TNK Part 2): A Multicenter, Randomized, Controlled Trial during the Thursday Main Event at the American Heart Association / American Stroke Association International Stroke Conference at the Los Angeles Convention Center.

copyright American Heart Association -Photo by Phil McCarten 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (2.9 MB) File Permalink

Bruce Campbell , M.B.B.S., B.Med.Sc., Ph.D.

Bruce Campbell, M.B.B.S. B.Med.Sc., Ph.D., head of stroke, Royal Melbourne Hospital and professorial fellow at the University of Melbourne, Parkville, Australia

 copyright Amanda Rebbechi, Royal Melbourne Hospital

Download (247.6 kB)
Bruce Campbell , M.B.B.S., B.Med.Sc., Ph.D.

Bruce Campbell , M.B.B.S., B.Med.Sc., Ph.D.

Bruce Campbell, M.B.B.S. B.Med.Sc., Ph.D., head of stroke, Royal Melbourne Hospital and professorial fellow at the University of Melbourne, Parkville, Australia

 copyright Amanda Rebbechi, Royal Melbourne Hospital


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (247.6 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Clot in brain illustration
  • Brain illustration
  • Clot busted with tPA illustration
  • Clot busting tPA administered illustration
  •  Bruce C. Campbell M.B.B.S., presents LB1
  • Bruce Campbell , M.B.B.S., B.Med.Sc., Ph.D.
  • ISC Logo

Related Video

Previous Slide Next Slide

Elkind ISC20 perspective on LB 1

Mitchell S. V. Elkind, M.D., M.S., FAHA, FAAN, president elect of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association and professor of neurology and epidemiology at Columbia University New York and attending neurologist at Columbia University Medical Center of the New York-Presbyterian Hospital.

News Release

Transcript (txt)

 

copyright American Heart Association

Download (262.0 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Elkind ISC20 perspective on LB 1

Mitchell S. V. Elkind, M.D., M.S., FAHA, FAAN, president elect of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association and professor of neurology and epidemiology at Columbia University New York and attending neurologist at Columbia University Medical Center of the New York-Presbyterian Hospital.

News Release

Transcript (txt)

 

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (262.0 MB) File Permalink

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 

Download (103.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (103.7 MB) File Permalink
  • Elkind ISC20 perspective on LB 1
  • Ischemic Stroke with tPA animation
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED